The Timed Up and Go Test can help identify some MS patients who might be at risk of falling.
The study looked at 204 people with Multiple Sclerosis (MS) who don’t use walking aids. They found that those who fell tended to take longer to complete the Timed Up and Go (TUG) Test, which measures how quickly someone can stand up, walk a short distance, turn around, and sit back down. For example, people who took longer than about 7.85 seconds on the test were more likely to fall. However, the test is only moderately effective, meaning it can miss some patients at risk or wrongly identify others as safe. This means that while the TUG Test is useful, it shouldn’t be the only test used to check for fall risks.
MS patients should care because understanding their fall risk can help them take steps to stay safe, like using assistive devices if needed. Caregivers can also benefit by knowing which patients might need extra support to prevent falls. Healthcare providers can use the TUG Test results to create better fall prevention plans tailored for each patient. Just like checking the weather before going outside helps you dress appropriately, knowing your fall risk can help you avoid accidents. Overall, this knowledge empowers patients and caregivers to make informed choices about safety.
The study involved a specific group of patients with low to moderate impairment, so results may not apply to everyone with MS. The TUG Test alone isn’t enough to predict falls, which means other assessments should also be considered. It’s important for patients and caregivers to discuss these findings with their healthcare team to understand the best safety strategies.
12/1/2025
Learn how anti-NMDAR encephalitis overlaps with MS and what it means for treatment and symptom manag
Read More12/1/2025
Learn how the PHH-1V booster shot could provide better COVID protection for MS patients and their ca
Read More12/1/2025
Discover how dignity affects family caregivers of MS patients and why their feelings matter for bett
Read More12/1/2025
Learn how studying certain viral genes in our DNA may lead to better MS treatments and improve sympt
Read More12/1/2025
Discover how gut bacteria may boost cognitive function in MS patients and why gut health matters for
Read More12/1/2025
Discover how targeting Piezo1 in immune cells could change MS management and improve symptoms for pa
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Disability and rehabilitation often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.